AERIAL: Changes in Health and Functional Status in Patients With COPD During Therapy With Spiolto Respimat
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2018
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms AERIAL
- Sponsors Boehringer Ingelheim
- 16 Nov 2018 Planned End Date changed from 18 Jan 2019 to 31 Jan 2019.
- 16 Nov 2018 Planned primary completion date changed from 18 Jan 2019 to 31 Jan 2019.
- 16 Nov 2018 Status changed from recruiting to active, no longer recruiting.